<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>33(17)</volume><submitter>Pang Y</submitter><pubmed_abstract>&lt;h4>Objective&lt;/h4>Epilepsy causes physical and mental damage to patients. As well known, microRNAs (miRNAs) provide therapeutic target potentials for patients with epilepsy. miR-128-3p was previously reported to be downregulated in temporal lobe epilepsy (TLE) patients, however, its detailed function in epilepsy is unknown.&lt;h4>Methods&lt;/h4>Astrocytes function in epilepsy, penicillin-induced astrocytes can be used as a model for seizures in vitro. Currently, the expression levels of mitogen-activated protein kinase 6 (MAPK6), interleukin-1 beta (IL-1β) and tumor necrosis factor-alpha (TNF-α) were determined by western blot and reverse transcription-quantitative PCR analyses (RT-qPCR). The expression level of miR-128-3p was evaluated by RT-qPCR. TargetScan 7.1 and dual luciferase reporter ass</pubmed_abstract><journal>Neuroreport</journal><pagination>742-749</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9622368</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>miR-128-3p inhibits the inflammation by targeting MAPK6 in penicillin-induced astrocytes.</pubmed_title><pmcid>PMC9622368</pmcid><pubmed_authors>Wang S</pubmed_authors><pubmed_authors>Pang Y</pubmed_authors><pubmed_authors>Luo D</pubmed_authors></additional><is_claimable>false</is_claimable><name>miR-128-3p inhibits the inflammation by targeting MAPK6 in penicillin-induced astrocytes.</name><description>&lt;h4>Objective&lt;/h4>Epilepsy causes physical and mental damage to patients. As well known, microRNAs (miRNAs) provide therapeutic target potentials for patients with epilepsy. miR-128-3p was previously reported to be downregulated in temporal lobe epilepsy (TLE) patients, however, its detailed function in epilepsy is unknown.&lt;h4>Methods&lt;/h4>Astrocytes function in epilepsy, penicillin-induced astrocytes can be used as a model for seizures in vitro. Currently, the expression levels of mitogen-activated protein kinase 6 (MAPK6), interleukin-1 beta (IL-1β) and tumor necrosis factor-alpha (TNF-α) were determined by western blot and reverse transcription-quantitative PCR analyses (RT-qPCR). The expression level of miR-128-3p was evaluated by RT-qPCR. TargetScan 7.1 and dual luciferase reporter ass</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2025-04-04T21:24:17.643Z</modification><creation>2025-04-04T21:24:17.643Z</creation></dates><accession>S-EPMC9622368</accession><cross_references><pubmed>36250437</pubmed><doi>10.1097/WNR.0000000000001840</doi></cross_references></HashMap>